Novavax Taps Ex-AstraZeneca Executive as CMO, Will Head Corornavirus Vaccine Development

Novavax (NASDAQ:NVAX) has a new, high-powered chief medical officer (CMO). The company announced Wednesday that it appointed Filip Dubovsky to the position. An industry veteran with more than 20 years of experience, he was most recently deputy CMO for clinical affairs at another global pharmaceutical major, AstraZeneca (NYSE:AZN).